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Scaling up health policies and services in
low- and middle-income settings
Kara Hanson1*, Susan Cleary2, Helen Schneider3, Sripen Tantivess4, Lucy Gilson1,5
“Scaling up” effective health services is high on the
policy agendas of many countries and international
agencies. The current concern has been driven by
growing recognition both of the challenges of achiev-
ing the health-related Millennium Development Goals
(MDGs) in many countries, and of the need to ensure
that the increased resources for health channelled
through disease-specific health initiatives are able gen-
erate health gain at scale. Effective and cost-effective
interventions exist to address many of the major
causes of disease burden in the developing world,
but coverage of many of these services remains low.
There is a substantial gap between what could be
achieved and what is actually being achieved in terms
of health improvement in low- and middle-income
countries.
The term “scaling up” is widely used as shorthand to
describe the objective or process of expanding service
delivery. As this broad definition suggests, the term
scaling up has been used in a variety of ways and con-
texts. For example, it can refer to the outcome, in
terms of increased coverage, or the inputs required,
whether financial, human or capital resources. Simi-
larly, scaling up can also refer to a policy, strategy or
the process of expansion [1]. The object of scaling up
can be particular health interventions (e.g. attended
delivery, insecticide treated mosquito nets, or inte-
grated management of childhood illness), or health
systems interventions such as health financing
mechanisms (community-based health insurance),
incentive mechanisms (e.g. pay-for-performance or
contracting) or approaches to service delivery (e.g.
training shopkeepers to supply antimalarial drugs).
A recent review article [1] and a set of accompanying
commentaries [2-4] documented the origins and use of
the term scaling up in international health, and
identified a number of critical themes or issues in
scaling up health policies and interventions:
- the cost of scaling up and resources required to
expand service delivery , including the trade-offs that
may arise between equity and efficiency
- the constraints to scaling up that operate at differ-
ent levels, from the household and community level
through to the service delivery, strategic and national
policy, and cross-sectoral levels
- the potential synergies and deleterious health sys-
tem effects of global health initiatives
- the opportunities afforded by novel approaches to
service delivery, including making use of private sec-
tor delivery channels.
However, despite increased conceptual clarity in this
area, there remains relatively little empirical evidence on
these themes. In June 2009 the Consortium for Research
on Equitable Health Systems (CREHS – http://www.
crehs.lshtm.ac.uk), a research programme funded by the
UK Department for International Development which
brings together 8 health policy and systems research
groups from 7 countries, hosted a writing workshop on
the theme of Scaling Up Health Policies and Interven-
tions. Workshop participants, drawn from CREHS mem-
bers and collaborators, presented and discussed research
they had been conducting across a variety of program-
matic areas linked to this theme. The eight papers in
this supplement represent a selection of the papers pre-
sented at this workshop. Together, they contribute a
rich set of new evidence about the barriers to scaling
up, the opportunities for overcoming these through
changes in financing arrangements and service delivery
innovations, and the critical importance of the processes
of managing change in order to realise the promise of
scaled up programmes and interventions.
The papers in this collection address three of
the priority health areas identified in the MDGs: anti-
retroviral therapy for the treatment of HIV/AIDS,
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reproductive health services (cervical cancer screening),
and malaria treatment. In addition, the first and last
papers have a generic, rather than disease-specific focus,
one examining issues of attracting and retaining health
workers in rural areas of Kenya, and the other proposing
an approach to evaluating the impact of novel service
delivery strategies.
Building on shared programmatic concerns, four other
important themes emerge from the papers:
(1) Costs and resource needs
There is a substantial literature estimating the cost of
scaling up individual interventions or packages of inter-
ventions, most recently represented in the report of the
Task Force on Innovative International Financing for
Health Systems [5]. Costing ARV scale-up is substan-
tially more complicated than other programmes because
once an individual begins ART, they must keep taking
the medicines for the rest of their life. The lifetime costs
of ART must therefore be modelled based on assump-
tions about not just the cost of first line therapy and the
number of new infections, but also the effects of ART
on longevity, the likelihood of needing to switch to sec-
ond line drugs, and the other health care costs that are
incurred such as management of opportunistic infec-
tions. The paper by Leisegang and colleagues [6] adds to
the literature on modelling the costs of scaling up ART
by analysing the variables that are associated with differ-
ent health outcomes and health care costs, using data
from a large cohort of individuals receiving ART in
South Africa.
Few costing studies make any serious attempt to
address the question of how these costs are to be
financed, or the appropriate contributions of domestic
vs. external financing. Cleary and McIntyre [7] link their
estimate of the cost of scaling up ART in South Africa
to proposals to reform the South African health finan-
cing system to develop a universal coverage scheme
based on a combination of contributory mandatory
insurance and increased tax funding. A key insight from
their paper is the relationship between ART access and
the broader policy context, noting that only by addres-
sing the fundamental inequities in the health financing
system will it be possible to achieve equitable, affordable
and sustainable ART access.
The shortage of human resources in many low-income
settings, particularly in rural areas, is a major constraint
to expanding service coverage. Mullei and colleagues [8]
examined the perceptions and attitudes of Kenyan nur-
sing school graduates towards working in rural areas in
order to identify policies that might encourage health
workers to locate to these underserved areas. They
found that nursing students hold a variety of positive
and negative attitudes towards working in rural areas.
As well as investments in higher salaries and improved
infrastructure, respondents identified changes in organi-
zational arrangements, including the ability to choose
their location, opportunities for more rapid career
advancement, and improvements in contractual condi-
tions, as policies that could contribute to a more equita-
ble distribution of health workers.
(2) Managing policy processes
Another scaling up challenge is the need for the related
policy development and implementation processes to be
managed strategically to support service expansion.
Three papers in this supplement address strategic man-
agement. Yothasamut et al. [9] consider both how
screening for cervical cancer was adopted, over the
human papilloma virus vaccine, as the preferred cervical
cancer prevention strategy in Thailand and how the
imperative of a political opportunity generated both
opportunities and challenges for its scaling up. Abuya et
al. [10] and Schneider et al. [11] focused, respectively,
on training programmes to improve malaria treatment
provided by shopkeepers in Kenya and on ART roll-out
in South Africa, both carefully examining implementa-
tion processes. Yothasamut et al. reflect a wider body of
evidence in showing how the agenda setting phase of
policy development is often influenced by contestation
between national and international policy actors sup-
porting different policy options, evidence around those
options and the timing of these debates in relation to a
national political window of opportunity [12]. That
opportunity, a government-wide programme of action,
spurred on implementation but also precluded the plan-
ning and preparation needed to support achievement of
scaling up goals. Abuya et al., meanwhile highlight the
local level action and learning needed to support effec-
tive scaling up of an innovative public health interven-
tion, and the need for deliberate but flexible
management strategies that respond to both unexpected
events and the more predictable tensions among imple-
menting actors. Finally, Schneider et al. illustrate the
importance of sub-national political and managerial sup-
port and leadership for scale up; the need to balance
standardisation with programme flexibility; and the sig-
nificance of “clinical” partnerships and monitoring and
evaluation systems.
(3) Private sector
Growing recognition of the role played by the private
sector in malaria treatment has led to interest in how to
improve the quality of treatment in this sector. Two
papers in this supplement address the use of the private
sector to deliver malaria medicines. Abuya et al. describe
three different projects which aimed to improve the
quality of malaria treatment in the informal sector
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through shopkeeper training. Because they involve mul-
tiple partners (private sector, local government or NGO
implementers, and technical teams which often come
from outside), these approaches raise particular issues of
strategic management. Cohen et al. [13] examine a small
scale programme pilot-testing an innovative mechanism
for subsidising artemisinin-based combination therapy
(ACTs) delivered through private drug shops in Tanza-
nia. The paper focuses on how distance mediates the
effect of price subsidies on both the decision by shops
to stock these new drugs and on sales volumes. The
paper demonstrates both the potential for the private
sector to increase coverage of effective malaria treat-
ment, and the need to be ever-vigilant that such
approaches address the needs of the poor. The results of
this project have fed directly into the decision to pilot
this approach at a national scale in 8 countries through
the Affordable Medicines Facility – malaria (AMFm),
managed by the Global Fund.
(4) Methods for studying scaling up
Webster et al. [14] review the literature evaluating service
delivery systems for malaria related interventions, includ-
ing insecticide-treated nets and intermittent preventive
treatment in pregnancy. They reflect on the complexity
of these systems and indicate that evaluation needs to
look comprehensively at the multiple steps in the delivery
process and at the multiple factors influencing it. Their
proposed method for evaluating service delivery arrange-
ments could be achieved through the insertion of ques-
tions in routine household surveys about the location
and mechanism of service provision to aid in attribution
of coverage outcomes to specific delivery systems.
The collection as a whole also points to the need to
develop and refine the methodology of health policy and
systems research for addressing scaling up. The papers
adopt a range of study designs and analytical approaches
– cross-sectional surveys, Markov and financial model-
ling techniques, case studies using a combination of
document review and qualitative data framed through
theory, and impact evaluation using a quasi experimen-
tal design. The main conclusion from these studies is
that scaling up processes are complex. Evaluations
should therefore not be limited to programme impact,
but must include a way of understanding and interpret-
ing the processes through which new activities are
implemented within the health system [10,11], and the
processes through which new ideas become policies [9].
More broadly, the studies support calls for new evalua-
tion approaches that take account of the complexity of
health interventions. De Savigny and Adam [6,15] for
example, have called for the application of “systems
thinking” approaches both in designing interventions
and evaluating them. They propose that evaluation
should include process evaluation (for adequacy), con-
text evaluation (for transferability), effects evaluation
(looking at both intended impacts and unintended con-
sequences), and economic evaluation (to address cost-
effectiveness considerations). Drawing on wider thinking
and experience around evaluating complex social pro-
grammes, these components also recognise the impor-
tance both of drawing multiple perspectives into the
development and evaluation of large scale interventions,
and of evaluation study designs that recognise multiple
pathways to outcomes and the likelihood of unexpected
consequences.
These papers are published at a critical time for health
systems: while some countries are on track to achieve
the 2015 MDG targets, others are faltering and action is
needed now to accelerate progress. Important gaps in
knowledge remain. In particular, our understanding of
both policy development and service delivery strategies
in fragile states is limited, and there is scope for
research on how to most effectively scale up services in
these environments. Perhaps most critical is the recogni-
tion that any scaling up process must include both
opportunities to learn through action and a way to feed
the lessons of experience into strategies to strengthen
implementation.
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